Transcriptome Profiling of Oocytes at the Germinal Vesicle Stage from Women from Mongolia with Polycystic Ovary Syndrome

References

• Ntumy M, Maya E, Lizneva D, et al. The pressing need for standardization.in epidemiologic studies of PCOS across the globe. Gynecol Endocrinol. 2019;35:1–3. doi:10.1080/09513590.2018.1488958
   PubMed Web of Science ®Google Scholar
• Olaniyi KS, Oniyide AA, Adeyanju OA, et al. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS. Toxicol Appl Pharmacol. 2020;411:115381. doi:10.1016/j.taap.2020.115381
   PubMed Web of Science ®Google Scholar
• Deepika K, Sindhuma D, Kiran B, et al. Empty follicle syndrome following GnRHa trigger in PCOS patients undergoing IVF cycles. J Reprod Fertil. 2018;19(1):16–25.
   Google Scholar
• Widecka J, Ozegowska K, Banaszewska B, et al. Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome? Ginekol Pol. 2019;90(3):115–121. doi:10.5603/GP.2019.0021
   PubMed Web of Science ®Google Scholar
• Palomba S, Daolio J, Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28(3):186–198. doi:10.1016/j.tem.2016.11.008
   PubMed Web of Science ®Google Scholar
• Krentowska A, Ebkowska A, Jacewicz-Wicka M, et al. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome. Endocrine. 2021;5:1–11.
   Google Scholar
• Wang F, Niu WB, Kong HJ, et al. The role of AMH and its receptor SNP in the pathogenesis of PCOS. Mol Cell Endocrinol. 2017;43(9):363–368. doi:10.1016/j.mce.2016.09.023
   Web of Science ®Google Scholar
• Murri M, Insenser M, Fernández-Durán E, et al. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones. Metab Clin Exp. 2018;86:49–60.
   PubMed Web of Science ®Google Scholar
• Vázquez-Martínez ER, Gómez-Viais YI, García-Gómez E, et al. DNA methylation in the pathogenesis of polycystic ovary syndrome. Reproduction. 2019;158(1):27–40. doi:10.1530/REP-18-0449
   Web of Science ®Google Scholar
• Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–336. doi:10.1097/AOG.0000000000002698
   PubMed Web of Science ®Google Scholar
• Cordeiro FB, Cataldi TR, de Souza BZ, et al. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome. Metabolomics. 2018;14(4):1–11. doi:10.1007/s11306-018-1350-z
   PubMed Web of Science ®Google Scholar
• Sánchez F, Lolicato F, Romero S, et al. An improved ivm method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield. Hum Reprod. 2017;32(10):2056–2068. doi:10.1093/humrep/dex262
   PubMed Web of Science ®Google Scholar
• Yang ZY, Chian RC. Development of in vitro maturation techniques for clinical applications. Fertil Steril. 2017;108(4):577–584. doi:10.1016/j.fertnstert.2017.08.020
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251–268. doi:10.1111/cen.13795
   PubMed Web of Science ®Google Scholar
• Jo J, Lee YJ. Effectiveness of acupuncture in women with polycystic ovarian syndrome undergoing in vitro fertilisation or intracytoplasmic sperm injection: a systematic review and meta-analysis. Acupunct Med. 2017;35(3):162. doi:10.1136/acupmed-2016-011163
   PubMed Web of Science ®Google Scholar
• Abedini M, Ghaedi E, Hadi A, et al. Zinc status and polycystic ovarian syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol. 2019;52:216–221. doi:10.1016/j.jtemb.2019.01.002
   PubMed Web of Science ®Google Scholar
• Sigala J, Sifer C, Dewailly D, et al. Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study. Fertil Steril. 2015;103(1):112–118. doi:10.1016/j.fertnstert.2014.09.040
   PubMed Web of Science ®Google Scholar
• Liu Q, Li Y, Feng Y, et al. Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV, MI, MII stages from PCOS patients. Sci Rep. 2016;6(1):39638. doi:10.1038/srep39638
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2019;37:1–13. doi:10.1093/nar/gkn923
   Web of Science ®Google Scholar
• Altmäe S, Mendoza-Tesarik R, Mendoza C, et al. Effect of growth hormone on uterine receptivity in women with RIF in an oocyte donation program: a randomized controlled trial. J Endocr Soc. 2018;2(1):96–105. doi:10.1210/js.2017-00359
   PubMed Web of Science ®Google Scholar
• Liu J, Wu DC, Qu LH, et al. The role of mtor in ovarian cancer, polycystic ovary syndrome and ovarian aging. Clin Anat. 2018;31:891–898. doi:10.1002/ca.23211
   PubMed Web of Science ®Google Scholar
• Emekci OO, Ozay AC, Acar B, et al. Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2016;32(9):1–5.
   Web of Science ®Google Scholar
• Gupta M, Yadav R, Mahey R, et al. Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes – a cross-sectional study. Gynecol Endocrinol. 2019;35(11):970–973. doi:10.1080/09513590.2019.1613640
   PubMed Web of Science ®Google Scholar
• Nilsson E, Zhang B, Skinner MK. Gene bionetworks that regulate ovarian primordial follicle assembly. BMC Genom. 2013;14(1):496. doi:10.1186/1471-2164-14-496
   PubMed Web of Science ®Google Scholar
• Cai L, Ma X, Liu S, et al. Effects of upregulation of Hsp27 expression on oocyte development and maturation derived from polycystic ovary syndrome. PLoS One. 2013;8(12):e83402. doi:10.1371/journal.pone.0083402
   PubMed Web of Science ®Google Scholar
• Wei LN, Huang R, Li LL, et al. Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome. J Assist Reprod Genet. 2014;31(11):1483–1490. doi:10.1007/s10815-014-0319-8
   PubMed Web of Science ®Google Scholar
• Karakose M, Demircan K, Tutal E, et al. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest. 2016;39(11):1–7. doi:10.1007/s40618-016-0472-2
   PubMed Web of Science ®Google Scholar
• Shen H, Liang Z, Zheng S, et al. Pathway and network-based analysis of genome wide association studies and rt-pcr validation in polycystic ovary syndrome. Int J Mol Med. 2017;40(5):1385–1396. doi:10.3892/ijmm.2017.3146
   PubMed Web of Science ®Google Scholar
• Koga Y, Tsurumaki H, Aoki-Saito H, et al. Roles of cyclic AMP response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system, osteoclast differentiation and mucin and cytokine production. Int J Mol Sci. 2019;20(6):1346. doi:10.3390/ijms20061346
   PubMed Web of Science ®Google Scholar
• Negron VM, Hansen PJ. Role of yes-associated protein 1, angiomotin, and mitogen-activated kinase kinase 1/2 in development of the bovine blastocyst. Biol Reprod. 2018;98(2):170–183. doi:10.1093/biolre/iox172
   PubMed Web of Science ®Google Scholar